메뉴 건너뛰기




Volumn 63, Issue 4, 2014, Pages 216-217

Which prophylactic therapies best prevent gout attacks?

Author keywords

[No Author keywords available]

Indexed keywords

ALLANTOIN; ALLOPURINOL; COLCHICINE; COLCHICINE PLUS PROBENECID; FEBUXOSTAT; NONSTEROID ANTIINFLAMMATORY AGENT; PEGLOTICASE; PROBENECID; URIC ACID; ANTIGOUT AGENT; MACROGOL DERIVATIVE; THIAZOLE DERIVATIVE; URATE OXIDASE;

EID: 84897497623     PISSN: 00943509     EISSN: 15337294     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (7)
  • 1
    • 56049101851 scopus 로고    scopus 로고
    • Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial
    • Schumacher HR Jr, Becker MA, Wortmann RL, et al. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Rheum. 2008;59:1540-1548.
    • (2008) Arthritis Rheum , vol.59 , pp. 1540-1548
    • Schumacher Jr., H.R.1    Becker, M.A.2    Wortmann, R.L.3
  • 3
    • 80051749331 scopus 로고    scopus 로고
    • Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: Two randomized controlled trials
    • Sundy JS, Baraf HSB, Yood RA, et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA. 2011;306:711-720.
    • (2011) JAMA , vol.306 , pp. 711-720
    • Sundy, J.S.1    Baraf, H.S.B.2    Yood, R.A.3
  • 4
    • 0016201345 scopus 로고
    • Prophylactic colchicine therapy of intercritical gout: A placebo-controlled study of probenecid-treated patients
    • Paulus HE, Schlosstein LH, Godfrey RG, et al. Prophylactic colchicine therapy of intercritical gout: a placebo-controlled study of probenecid-treated patients. Arthritis Rheum. 1974;17:609-614.
    • (1974) Arthritis Rheum , vol.17 , pp. 609-614
    • Paulus, H.E.1    Schlosstein, L.H.2    Godfrey, R.G.3
  • 6
    • 84869186940 scopus 로고    scopus 로고
    • 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
    • American College of Rheumatology
    • Khanna D, Fitzgerald JD, Khanna PP, et al American College of Rheumatology. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken). 2012;64:1431-1446.
    • (2012) Arthritis Care Res (Hoboken) , vol.64 , pp. 1431-1446
    • Khanna, D.1    Fitzgerald, J.D.2    Khanna, P.P.3
  • 7
    • 84869180170 scopus 로고    scopus 로고
    • 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and anti-inflammatory prophylaxis of acute gouty arthritis
    • American College of Rheumatology
    • Khanna D, Khanna PP, Fitzgerald JD, et al American College of Rheumatology. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and anti-inflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken). 2012;64: 1447-1461.
    • (2012) Arthritis Care Res (Hoboken) , vol.64 , pp. 1447-1461
    • Khanna, D.1    Khanna, P.P.2    Fitzgerald, J.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.